Open access · CC-BY
via OpenAlex
Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update
Mayra Colardo, Marco Segatto, Sabrina Di Bartolomeo
International Journal of Molecular Sciences · 2021 · ▲ 140 citations
Abstract
Gliomas are the most common and challenging malignancies of the central nervous system (CNS), due to their infiltrative nature, tendency to recurrence, and poor response to treatments. Indeed, despite the advances in neurosurgical techniques and in radiation therapy, the modest effects of therapy are still challenging. Moreover, tumor recurrence is associated with the onset of therapy resistance; it is therefore critical to identify effective and well-tolerated pharmacological approaches capable of inducing durable responses in the appropriate patient groups. Molecular alterations of the RTK/PI3K/Akt/mTOR(definition) signaling pathway are typical hallmarks of glioma, and several clinical trials targeting one or more players of this axis have been launched, showing disappointing results so far, due to the scarce BBB permeability of certain compounds or to the occurrence of resistance/tolerance mechanisms. However, as RTK/PI3K/mTOR is one of the pivotal pathways regulating cell growth and survival in cancer biology, targeting still remains a strong rationale for developing strategies against gliomas. Future rigorous clinical studies, aimed at addressing the tumor heterogeneity, the interaction with the microenvironment, as well as diverse posology adjustments, are needed-which might unravel the therapeutic efficacy and response prediction of an RTK/PI3K/mTOR-based approach.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms22094899
- Canonical
- link ↗
- Fetched
- 2026-08-24 MST
Cite this
APA
Colardo, M., Segatto, M., & Bartolomeo, S.D. (2021). Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms22094899
Vancouver
Colardo M, Segatto M, Bartolomeo SD. Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update. International Journal of Molecular Sciences. 2021. doi:10.3390/ijms22094899.
BibTeX
@article{mayra2021Target,
title = {Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update},
author = {Mayra Colardo and Marco Segatto and Sabrina Di Bartolomeo},
journal = {International Journal of Molecular Sciences},
year = {2021},
doi = {10.3390/ijms22094899},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Biology 2017
Open access · OA
An Intracellular Pathogen Response Pathway Promotes Proteostasis in C. elegans
Journal of Clinical Medicine 2020
Open access · CC-BY
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
Cell Reports Medicine 2023
Open access · CC-BY
Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma
Aging Cell 2011
Open access · OA
Celecoxib extends C. elegans lifespan via inhibition of insulin-like signaling but not cyclooxygenase-2 activity
Cancer and Metastasis Reviews 2021
Open access · CC-BY
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations
Signal Transduction and Targeted Therapy 2021
Open access · CC-BY